CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Open-market sale Director sold 4,000 shares at $36.36 ($145,440)
- 4 Grant or award EVP, GC, CCO & Corp Sec acquired 19,497 shares (grant or award)
- 4 Grant or award CEO, President acquired 53,915 shares (grant or award)
- 4 Grant or award EVP, Chief Medical Officer acquired 18,894 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 19,430 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 20,636 shares (grant or award)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 3,546 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, GC, CCO & Corp Sec gave up 3,546 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 3,546 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, President gave up 7,607 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 3,758 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 5,718 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 5,488 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, GC, CCO & Corp Sec gave up 3,968 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, President gave up 84,745 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 2 of 34 · 664 filings